NCT00005968View on ClinicalTrials.gov

Irofulven in Treating Patients With Stage IV Melanoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 1999

Primary Completion Date

December 31, 2002

Study Completion Date

December 31, 2002

Conditions
Melanoma (Skin)
Interventions
DRUG

irofulven

Trial Locations (5)

60068

Lutheran General Hospital, Park Ridge

65203

Ellis Fischel Cancer Center - Columbia, Columbia

80220

Veterans Affairs Medical Center - Denver, Denver

80262

University of Colorado Cancer Center, Denver

90404

John Wayne Cancer Institute, Santa Monica

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Colorado, Denver

OTHER

NCT00005968 - Irofulven in Treating Patients With Stage IV Melanoma | Biotech Hunter | Biotech Hunter